Aggregation inhibitors or anticoagulants in the prevention of peripheral arterial occlusive diseases
Loew, D.; Hess, H.
Die Medizinische Welt 33(43): 1511-1515
1982
ISSN/ISBN: 0025-8512 PMID: 6759847 Document Number: 190527
Document emailed within 1 workday
Related Documents
Bollinger, A. 1987: Secondary prevention of peripheral arterial occlusive diseases Therapeutische Umschau. Revue Therapeutique 44(9): 682-685Breddin, J.; Hess, H. 1981: Should one employ anticoagulants or platelet inhibitors in the long-term prophylaxis, with or without surgery, of arterial occlusive disease? Die Medizinische Welt 32(37): 1343-1344
Benner, K.U.; Geeren, M.; Burstedde, V.; Everts, B. 1984: Platelet aggregation abnormalities in arterial occlusive diseases (AOD) Journal of Medicine 15(1): 23-34
Pfisterer, M.; Jockers, G.; Meier, B.; Schmitt, H.E.; Stulz, P.; Hasse, J.; Grädel, E.; Burkart, F. 1987: Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study Helvetica Chirurgica Acta 53(4): 497-500
Alexander, K. 1993: Conservative therapy of peripheral arterial occlusive diseases Zeitschrift für Kardiologie 82(Suppl): 89-98
Moucka, J.; Jäger, K. 1990: Rational approach to peripheral arterial occlusive diseases Schweizerische Rundschau für Medizin Praxis 79(50): 1553-1559
Altmann, E.; Schmidt, P.K. 1987: Expert assessment of peripheral arterial occlusive diseases Zeitschrift für Arztliche Fortbildung 81(17): 911-913
Inoue, Y. 2016: Open surgical treatment for peripheral arterial occlusive diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 2): 337-342
Hubl, S.; Wesolowski, J. 1973: Intra-arterial administration of penicillin and vasodilating agents in occlusive diseases of the peripheral arteries Polski Tygodnik Lekarski 28(30): 1150-1151
Heidrich, H. 1978: Defibrination with ancrod (arvin) in peripheral arterial occlusive diseases. Principle, indications, contraindications technic and course Zfa. Zeitschrift für Allgemeinmedizin 54(32): 1648-1651
Makoski, H.B. 1995: Prevention of recurrence after stent implantation in arterial occlusive diseases Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(3): 178
Marshall, M. 1982: Thrombocyte function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 1. Pathogenesis, prevention, therapy Fortschritte der Medizin 100(14): 650-655
Ferreira, R. 1992: First Course of cardiovascular clinical pharmacology. II. Adjuvant therapy to thrombolysis. Anticoagulants and platelet aggregation inhibitors Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 261-264
Gupta, M.C.; Dhamija, J.P.; Mathur, D.S.; Sharma, B.M. 1983: Role of propranolol and aspirin in decreasing platelet aggregation in occlusive cerebrovascular diseases Journal of the Association of Physicians of India 31(9): 565-567
Lebrun, T.; Selke, B.; Sailly, J.C.; Boissier, C.; Mosnier, M. 1994: The introduction of economic criteria into the management of arterial disease: an illustration with regard to the socioeconomic consequences of peripheral occlusive arterial disease of the lower limbs Journal of Cardiovascular Pharmacology 23(Suppl 3): S17-S21
Spittell, J.A. 1992: Conservative management of occlusive peripheral arterial disease Cardiovascular Clinics 22(3): 209-215
Ratnatunga, C. 1998: Chronic peripheral occlusive arterial disease in Sri Lanka Ceylon Medical Journal 43(4): 182-184
Kröger, K. 2005: Peripheral arterial occlusive disease--the forgotten arteriosclerosis MMW Fortschritte der Medizin 147(18): 21
Cole, C.W.; Hill, G.B.; Farzad, E.; Bouchard, A.; Moher, D.; Rody, K.; Shea, B. 1993: Cigarette smoking and peripheral arterial occlusive disease Surgery 114(4): 753
Périard, D.; Hayoz, D.; Mazzolai, L. 2009: Medical therapy in peripheral arterial occlusive disease Revue Medicale Suisse 5(189): 312-315